Yahoo Web Search

Search results

  1. Andrew J. Conrad is an American geneticist who heads Verily, a life sciences division of Alphabet Inc. As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.

  2. Andrew Conrad, PhD, is the Chief Executive Officer, Chairman and Founder of Verily where he oversees an integrated team of engineers, scientists, designers, ...

    • 28 min
    • 416
    • Axial
  3. verily.com › about-us › leadershipverily.com

    We would like to show you a description here but the site won’t allow us.

  4. Feb 22, 2024 · Andy Conrad, the founder of Alphabet Inc.’s life sciences unit Verily, has joined venture capital firm S32 as a general partner as the firm seeks to deepen its investments in the...

  5. Andrew Conrad is a healthcare entrepreneur and investor who leads Verily, a subsidiary of Alphabet. He also serves on the board of Genalyte, a biotech company, and advises SandboxAQ, an edtech startup.

    • Male
    • Verily
    • 564 Market St. Suite 700, San Francisco, 94104, CA
  6. Dec 22, 2021 · Gillett, who joined Verily as COO in 2020, will work with CEO Andy Conrad and other executives to grow the Alphabet offshoot. Conrad will focus on long-term strategy, business development and partnerships.

  7. Dec 21, 2021 · Verily CEO Andy Conrad is taking a longer-term, more strategic role at the Alphabet life sciences company and is promoting chief operating officer Stephen Gillett to president and COO.